VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
PACB
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
PACBPacific Biosciences of California, Inc.
$2.26$702M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksPACBPrice History

PACB logoPacific Biosciences of California, Inc. (PACB) Stock Price History

Historical prices from 2010 to 2026

$2.26-0.17  (-7.00%)close Nov 6
Returns
1M
-16.5%
3M
+92.7%
YTD
+22.6%
1Y
+26.7%
3Y
-30.8%
5Y
-40.2%
ATH$53.69Feb 2021-95.8%
ATL$0.85May 2025pre-split
Avg Vol (50D)13.9M/ day
52-Week Range$1.07 — $3.44
LowCurrent: $2.26High

Loading 10-year price history...

PACB Historical Performance

1 YearTotal Return
+26.7%
Price: +26.7%
3 YearsTotal Return
-66.8%
CAGR: -30.8%
Price: -66.8%
5 YearsTotal Return
-92.4%
CAGR: -40.2%
Price: -92.4%
YTD
+22.6%

PACB Annual Returns

Year-by-year price performance · 2010–2026

Best+402.7%2020
Worst-82.8%2011
Up years8/17
2010-3.2%
2011-82.8%
2012-42.4%
2013+182.7%
2014+54.6%
2015+68.1%
2016-71.2%
2017-39.4%
2018+165.2%
2019-30.5%
2020+402.7%
2021-22.4%
2022-60.9%
2023+23.6%
2024-80.9%
2025+3.9%
2026+26.6%
2010 annual price return
-3.2%
2011 annual price return
-82.8%
2012 annual price return
-42.4%
2013 annual price return
+182.7%
2014 annual price return
+54.6%
2015 annual price return
+68.1%
2016 annual price return
-71.2%
2017 annual price return
-39.4%
2018 annual price return
+165.2%
2019 annual price return
-30.5%
2020 annual price return
+402.7%
2021 annual price return
-22.4%
2022 annual price return
-60.9%
2023 annual price return
+23.6%
2024 annual price return
-80.9%
2025 annual price return
+3.9%
2026 annual price return
+26.6%
LessMore
Alpha vs S&P 500
1Y+17.0%
3Y-48.1%
5Y-48.7%

Price returns only.

Download Historical Data

4,032 records • Includes OHLCV + Technical Indicators (MA50, MA200, RSI)

Free sign in required to download data

PACB Stock Price Trajectory (2010–2026)

As of November 8, 2026, Pacific Biosciences of California, Inc. (PACB) trades at $2.26, representing a +26.7% return over the past year. The stock has delivered a -92.4% total return over five years (-40.2% CAGR), reflecting challenging market conditions.

The stock reached its all-time high of $53.69 on February 11, 2021. From this peak, PACB has corrected -95.8%, currently trading 40% above its 200-day moving average, indicating continued institutional support.

When compared to Healthcare sector peers ILMN (+76.0% 1Y), BFLY (+183.1% 1Y), and CDNA (+423.4% 1Y), PACB has underperformed the peer group average. Compare PACB vs ILMN →

PACB Historical Price Data · from 2010

Rows 1–50 of 4,032
Date Open High Low Close Volume Change %
2026-11-062.432.542.242.269.53M-7.00%
2026-11-052.242.692.232.4320.58M-4.71%
2026-11-042.532.702.482.5520.97M+4.51%
2026-11-032.412.582.402.446.26M+3.83%
2026-11-022.682.722.312.359.10M-9.96%
2026-10-302.752.822.412.6113.74M-10.00%
2026-10-292.782.962.742.9011.97M+2.47%
2026-10-282.453.072.442.8335.05M+15.51%
2026-10-272.262.532.232.4518.69M+8.89%
2026-10-262.122.312.082.259.57M+6.64%
2026-10-232.022.131.972.115.72M+2.43%
2026-10-222.132.212.052.069.18M-3.74%
2026-10-211.972.191.922.1413.50M+9.18%
2026-10-201.822.061.761.9610.36M+6.52%
2026-10-191.781.861.741.846.04M+6.36%
2026-10-161.961.961.701.7310.43M-11.73%
2026-10-151.932.001.861.9612.62M-1.51%
2026-10-142.002.081.951.999.21M-2.93%
2026-10-132.072.141.992.0512.29M-2.38%
2026-10-122.242.292.012.1012.08M-9.87%
2026-10-092.362.472.212.3312.82M+1.30%
2026-10-082.632.692.222.3024.14M-15.44%
2026-10-072.622.742.502.7220.37M+0.74%
2026-10-063.023.442.432.7047.11M-5.92%
2026-10-052.532.922.512.8726.25M+12.99%
2026-10-022.502.652.442.5426.01M+1.20%
2026-10-012.342.562.322.5135.87M+5.91%
2026-09-301.842.461.842.3780.39M+29.51%
2026-09-291.681.851.631.8317.42M+7.02%
2026-09-281.601.801.591.7121.28M+5.56%
2026-09-251.571.631.521.6211.37M+2.53%
2026-09-241.401.591.381.5811.10M+12.06%
2026-09-231.451.471.391.415.26M-4.08%
2026-09-221.381.481.361.477.85M+8.09%
2026-09-211.371.401.341.366.13M-0.73%
2026-09-181.381.401.341.374.96M-0.72%
2026-09-171.371.431.361.386.23M+2.99%
2026-09-161.341.401.321.345.32M0.00%
2026-09-151.361.411.341.345.60M-0.74%
2026-09-141.281.381.281.354.72M+3.85%
2026-09-111.291.321.281.303.73M+2.36%
2026-09-101.261.311.251.274.71M-1.55%
2026-09-091.311.341.261.294.16M-2.27%
2026-09-081.341.361.301.323.99M-2.22%
2026-09-041.301.351.291.352.76M+3.85%
2026-09-031.331.351.281.305.15M-1.52%
2026-09-021.291.341.281.325.94M+3.13%
2026-09-011.331.341.281.286.04M-5.88%
2026-08-311.401.441.331.366.08M-2.86%
2026-08-281.521.551.391.405.23M-9.68%
…
Consensus & Technical Research Suite
Open PACB Terminal

PACB Chart Terminal

WASM

Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.

Launch Terminal

Live Breakouts Feed

LIVE

High-probability breakout stocks crossing their pivot across 5 pattern engines.

Explore Setups

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

PACB — Frequently Asked Questions

Quick answers to the most common questions about buying PACB stock.

How has PACB stock performed recently?

PACB returned +26.7% over the past year, beating its 5-year annualized CAGR of -40.2%. The stock trades above its 200-day moving average, confirming the uptrend.

What is PACB's all-time high price?

Pacific Biosciences of California, Inc. reached $53.69 on 2021-02-11. The 52-week high is $3.44. Current 1-year return of +26.7% places the stock closer to historical peaks.

Where can I download PACB historical price data?

This page provides PACB daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2010-2026, downloadable in CSV format.

449 data points · sampled from 4,032